首页> 外文期刊>The journal of sexual medicine >Injection Anxiety and Pain in Men Using Intracavernosal Injection Therapy after Radical Pelvic Surgery
【24h】

Injection Anxiety and Pain in Men Using Intracavernosal Injection Therapy after Radical Pelvic Surgery

机译:盆腔根治性手术后使用海绵体腔内注射疗法治疗男性注射性焦虑和疼痛

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Intracavernosal injection (ICI) therapy is a well-recognized treatment strategy with high success rates for men with erectile dysfunction. Despite this, injection anxiety and pain related to injection are significant barriers to its use. Aims: This study aims to examine injection anxiety and injection pain in patients using ICI. Methods: Men starting ICI therapy post radical pelvic surgery completed questionnaires at initial visit, at each of the two ICI training sessions and at a 4-month follow-up visit. Main Outcome Measures: Injection Anxiety Scale, Injection Pain Scale, Injection Reaction Inventory, and the Erectile Function Domain of the International Index of Erectile Function. Results: Average age of the 68 men was 60±8 years. At 4 months, the self-reported frequency of ICI use was: 29% <1/week, 26% 1/week, 40% 2/week, and 5% 3/week. Mean injection anxiety score at first injection was 5.7±2.8 (range 0-10) and significantly decreased to a 4.1±3 at 4 months (P<0.001). At first injection, 65% reported high injection anxiety (≥5) and this significantly decreased to 42% (P=0.003) at 4 months. Anxiety at first injection was negatively related to ICI frequency at 4 months (r=-0.23, P=0.08). Mean injection pain score at first injection was low (2.2±1.8, range 0-10) and 59% rated injection pain ≤2. Injection pain remained consistent across time periods. At first injection, injection anxiety (assessed prior to injection) was related to injection pain (r=0.21, P=0.04) and subjects (n=21) who reported high injection anxiety (≥5) across time points, reported an increase in injection pain scores from first injection to 4 months (2.7 vs. 3.7, P=0.05). Conclusions: Although injection anxiety decreased with ICI use, mean injection anxiety remained at a moderate level (4.4) and 42% of men continued to report "high" injection anxiety at 4 months. While injection pain was low, injection anxiety and pain were related. These data suggest the need for a psychological intervention to help lower injection anxiety related to ICI.
机译:简介:腔内注射(ICI)治疗是一种公认​​的治疗策略,对于勃起功能障碍的男性成功率很高。尽管如此,与注射有关的注射焦虑和疼痛仍是其使用的重要障碍。目的:本研究旨在检查使用ICI的患者的注射焦虑和注射疼痛。方法:进行根治性盆腔手术后开始ICI治疗的男性在初次就诊,两次ICI培训课程中的每一次以及4个月的随访中均填写了问卷。主要观察指标:注射焦虑量表,注射疼痛量表,注射反应量表和国际勃起功能指数勃起功能域。结果:68名男性的平均年龄为60±8岁。在4个月时,自我报告的ICI使用频率为:29%<1 /周,26%1 /周,40%2 /周和5%3 /周。首次注射时的平均注射焦虑评分为5.7±2.8(范围为0-10),并在4个月时显着降低至4.1±3(P <0.001)。初次注射时,有65%的人报告了很高的注射焦虑(≥5),并且在4个月时显着下降至42%(P = 0.003)。首次注射时的焦虑与4个月时ICI频率呈负相关(r = -0.23,P = 0.08)。首次注射时的平均注射疼痛评分较低(2.2±1.8,范围为0-10),且额定注射疼痛的2%≤2。注射疼痛在各个时期保持一致。在第一次注射时,注射焦虑(在注射前评估)与注射疼痛有关(r = 0.21,P = 0.04),并且在各个时间点报告高注射焦虑(≥5)的受试者(n = 21)报告其焦虑增加。从首次注射到4个月的注射疼痛评分(2.7比3.7,P = 0.05)。结论:虽然注射焦虑随着ICI的使用而降低,但平均注射焦虑仍保持在中等水平(4.4),并且42%的男性在4个月后继续报告“高度”注射焦虑。尽管注射疼痛很低,但注射焦虑和疼痛却相关。这些数据表明需要心理干预以帮助降低与ICI相关的注射焦虑症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号